CS logo
small CS logo
South Tyneside District Hospital

South Shields, England, United Kingdom
Hospital in South Shields, England
Harton Ln, South Shields NE34 0PL

About South Tyneside District Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Newcastle-upon-Tyne Hospitals NHS Trust
2
South Tyneside and Sunderland NHS Foundation Trust
2
University College, London
2
Velindre NHS Trust
2
Anglo Celtic Cooperative Oncology Group
1
ETOP IBCSG Partners Foundation
1
Medical Research Council
1
Owlstone Ltd
1
Portsmouth Hospitals NHS Trust
1
Prostate Cancer Clinical Trials Consortium
1
Total Rows: 14

Clinical Trials at South Tyneside District Hospital


During the past decade, South Tyneside District Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1133332200110000Started TrialsCompleted Trails201520162017201801234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer
2001-10-01
Unknown status
816
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years
2004-01-01
2010-12-01
Completed
175
Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
2005-03-01
Unknown status
2,421
Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil
2006-12-01
Completed
1,198
Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery
2006-10-01
2013-03-01
Completed
1,000
Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer
2007-01-01
2013-11-01
Completed
846
Dalteparin in Preventing Blood Clots in Patients With Lung Cancer
2007-08-01
Unknown status
2,200

Rows per page:

1–19 of 19

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "South Tyneside District Hospital" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Newcastle-upon-Tyne Hospitals NHS Trust" with 2 trials sponsored, "South Tyneside and Sunderland NHS Foundation Trust" with 2 trials sponsored, "University College, London" with 2 trials sponsored and "Velindre NHS Trust" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "South Tyneside District Hospital" #1 collaborator was "ARC Medical Design Ltd" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Barnet and Chase Farm Hospitals NHS Trust" with 1 trials as a collaborator and "Berry Consultants" with 1 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 53 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 2Boehringer Ingelheim: 2Newcastle-upon-TyneHospitals NHS Trust: 2Newcastle-upon-TyneHospitals NHS Trust: 2South Tyneside andSunderland NHSFoundation Trust: 2South Tyneside andSunderland NHSFoundation Trust: 2University College, London: 2University College, London: 2Velindre NHS Trust: 2Velindre NHS Trust: 2Anglo CelticCooperative OncologyGroup: 1Anglo CelticCooperative OncologyGroup: 1ETOP IBCSG PartnersFoundation: 1ETOP IBCSG PartnersFoundation: 1Medical Research Council: 1Medical Research Council: 1Owlstone Ltd: 1Owlstone Ltd: 1Portsmouth HospitalsNHS Trust: 1Portsmouth HospitalsNHS Trust: 1

Created with Highcharts 11.1.0Top CollaboratorsARC Medical Design Ltd: 1ARC Medical Design Ltd: 1AstraZeneca: 1AstraZeneca: 1Australian and NewZealand Intensive CareResearch Centre: 1Australian and NewZealand Intensive CareResearch Centre: 1Barnet and Chase FarmHospitals NHS Trust: 1Barnet and Chase FarmHospitals NHS Trust: 1Berry Consultants: 1Berry Consultants: 1Blackpool TeachingHospitals NHSFoundation Trust: 1Blackpool TeachingHospitals NHSFoundation Trust: 1Breast International Group: 1Breast International Group: 1British Heart Foundation: 1British Heart Foundation: 1British Lung Foundation: 1British Lung Foundation: 1BuckinghamshireHealthcare NHS Trust: 1BuckinghamshireHealthcare NHS Trust: 1

Clinical Trials Conditions at South Tyneside District Hospital


According to Clinical.Site data, the most researched conditions in "South Tyneside District Hospital" are "Lung Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Breast Cancer" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials) and "Adenoma" (1 trials). Many other conditions were trialed in "South Tyneside District Hospital" in a lesser frequency.

Clinical Trials Intervention Types at South Tyneside District Hospital


Most popular intervention types in "South Tyneside District Hospital" are "Drug" (10 trials), "Biological" (5 trials), "Other" (5 trials), "Procedure" (5 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "quality-of-life assessment" (2 trials), "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials) and "Anakinra" (1 trials). Other intervention names were less common.

Clinical Trials Genders at South Tyneside District Hospital


The vast majority of trials in "South Tyneside District Hospital" are 16 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at South Tyneside District Hospital


Currently, there are NaN active trials in "South Tyneside District Hospital". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in South Tyneside District Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in South Tyneside District Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Not Applicable: 4Not Applicable: 4Phase 2: 1Phase 2: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Recruiting: 5Recruiting: 5Unknown status: 4Unknown status: 4Active, not recruiting: 1Active, not recruiting: 1